iRadimed Q3 Adj. EPS $0.55, Inline, Sales $24.203M Beat $23.467M Estimate
Benzinga Newsdesk 22 hours ago
NewsEarningsEarnings Beats
iRadimed (NASDAQ:IRMD) reported quarterly earnings of $0.55 per share which met the analyst consensus estimate. This is a 17.02 percent increase over earnings of $0.47 per share from the same period last year. The
iRadimed (NASDAQ:IRMD) reported quarterly earnings of $0.55 per share which met the analyst consensus estimate. This is a 17.02 percent increase over earnings of $0.47 per share from the same period last year. The company reported quarterly sales of $24.203 million which beat the analyst consensus estimate of $23.467 million by 3.14 percent. This is a 14.15 percent increase over sales of $21.202 million the same period last year.